Optimized use of cross-sectional imaging for the early diagnosis and management of ankylosing spondyloarthropathy;Comment intégrer l'imagerie moderne dans le diagnostic précoce et le suivi de la spondylarthrite ankylosante?

Journal de Radiologie

Volumn 91, Issue 1 C2, 2010, Pages 162-172

  Kemta Lekpa, F ^a   Lenczner, G ^a   Farrenq, V ^a   Claudepierre, P ^a  

^a Hopital Albert Chenevier   (France)

Author keywords

Ankylosing spondyloarthropathy; Early diagnosis; MRI

Indexed keywords

C REACTIVE PROTEIN; CELECOXIB; GADOLINIUM; HLA B27 ANTIGEN; STROMELYSIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; ARTHRITIS; CROHN DISEASE; DOPPLER FLOWMETRY; EARLY DIAGNOSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; INFLAMMATION; LUMBAR SPINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PSORIASIS; REVIEW; SACROILIAC JOINT; SACROILIITIS;

EID: 77949404309     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0221-0363(10)70021-4     Document Type: Review

References (42)

1. Combe B, Landewé R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45.
2. van der Heijde D, Landewé R, Einstein S, et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 2008;58:1324-31.
3. van der Heijde D, Landewé R, Baraliakos X, Houben H, et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008;58: 3063-70.
4. van der Heijde D et al. Adalimumab (Humira®) therapy for ankylosing spondylitis over 2 years does not demonstrate inhibition of radiographic progression compared with a historical control group. Arthritis Rheum 2008; 58: S670.
5. Claudepierre P, Wendling D. Are inflammation and ossification on separate tracks in ankylosing spondylitis? Joint Bone Spine 2008; 75:520-2.
6. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early? Ann Rheum Dis 2004; 63:535-43.
7. Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988;15:1109-14.
8. Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23:61-6.
9. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum. 1984; 4: 361-368.
10. Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717-27.
11. Ahlström H, Feltelius N, Nyman R, Hällgren R. Magnetic resonance imaging of sacroiliac joint inflammation. Arthritis Rheum 1990;33:1763-9.
12. Forrester DM. Imaging of the sacroiliac joints. Radiol Clin North Am. 1990;28:1055-72.
13. König H, Sauter R, Deimling M, Vogt M. Cartilage disorders: comparison of spin-echo, CHESS, and FLASH sequence MR images. Radiology 1987;164:753-8.
14. Braun J, Bollow M, Eggens U, Konig H, Distler A, Sieper J. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994;37:1039-45.
15. Bollow M, Braun J, Hamm B, et al. Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadoliniumenhanced MR imaging. Radiology 1995;194:529-36.
16. Puhakka KB, Jurik AG, Egund N, et al. Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiol 2003;44:218-29.
17. Oostveen J, Prevo R, den Boer J, van de Laar M. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J Rheumatol 1999;26:1953-8.
18. Bennett AN, McGonagle D, O'Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondbylitis at eight years. Arthritis Rheum 2008;58: 3413-8.
19. Heuft-Dorenbosch L, Landewé R, Weijers R, et al. Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain. Ann Rheum Dis 2006;65:804-8.
20. Pham T, Fautrel B, Dernis E et al. Recommendations of the French Society for Rheumatology regarding TNF alpha antagonist therapy in patient with ankylosing spondylitis or psoriatic arthritis: 2007 update. Joint Bone Spine 2007; 74:638-46.
21. Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008; 67:1276-81.
22. Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on Magnetic Resonance Imaging (MRI) for classification of axial spondyloarthritis - a consensual approach by the ASAS/ OMERACT MRI Group. Ann Rheum Dis. 2009 May 18. [Epub ahead of print] PubMed PMID: 19454404.
23. Maksymowych WP, Lambert RG. Magnetic resonance imaging for spondyloarthritis-avoiding the minefield. J Rheumatol 2007; 34:259-65. 24. Bennett AN, Rehman A, Hensor EM, Marzo-Ortega H, Emery P, McGonagle D. Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondylarthritis. Arthritis Rheum 2009;60:1331-41.
24. Weber U, Hodler J, Jurik AG, et al. Assessment of active spinal inflammatory changes in patients with axial spondylarthropathis: Validation of whole body MRI against conventional MRI. Ann Rheum Dis published online 4 May 2009; doi:10.1136/ard.2009. 108274.
25. Song I, Hilgert E, Brandt HC, Spiller I, Sieper J, Rudwaleit M. Inflammatory lesions on Magnetic Resonance Imaging in the Spine and Sacroiliac Joints in Patients with Non-radiographic axial Sponyloarthritis. Abstract 519. American College of Rheumatology. 2008 Annual Scientific Meeting
26. Claudepierre P, Voisin MC. The entheses: histology, pathology, and pathophysiology. Joint Bone Spine 2005; 72:32-7.
27. D'Agostino M-A, Said-Nahal R, Hacquard-Bouder C, Brasseur J-L, Dougados M, Breban M. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power doppler. Arthritis Rheum 2003; 48:523-533.
28. McGonagle D, Marzo-Ortega H, O'Connor P, et al. The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 2002;46:489-93.
29. Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 2002;61:905-10.
30. Rudwaleit M, van der Heijde D, Landewé R, et al. The Development of Assessment of SpondyloArthritis international Society (ASAS) Classification Criteria for Axial Spondyloarthritis (Part II): Validation and Final Selection. Ann Rheum Dis 2009;68:777-83.〉
31. van der Heijde D, Bellamy N, Calin A et al. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol 1997;24:2225-9.
32. Wanders A, Landewe R, Dougados M et al. Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? Ann Rheum Dis 2005;64:988-94.
33. Landewé R, Dougados M, Mielants H, van der Tempel H, van der Heijde D. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis. 2009;68:863-7.
34. Calin A, Mackay K, Santos H, Brophy S. A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. J Rheumatol 1999;26:988-92.
35. Taylor HG, Wardle T, Beswich EJ, Dawes PT. The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Br J Rheumatol 1991;30:330-5.
36. Creemers MCW, Franssen MJ, van't HOF MA, Gribnau FWJ, van de Putte LBA, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005;64:127-9.
37. Baraliakos X, Listing J, Rudwaleit M, et al. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 2007;66:910-5.
38. Baraliakos X, Listing J, von der Recke A, Braun J. The Natural Course of Radiographic Progression in Ankylosing Spondylitis - Evidence for Major Individual Variations in a Large Proportion of Patients. J Rheumatol. 2009 Mar 30. [Epub ahead of print]
39. Maksymowych WP, Landewé R, Conner-Spady B, et al. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 2007;56:1846-53.
40. Wanders A, Heijde D, Landewé R, et al. Nonsteroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005;52:1756-65.
41. Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Østergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009;60:93-102.
42. Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008;10: R104.